Skip to main content
Clinical Trials/CTRI/2024/07/070768
CTRI/2024/07/070768
Not yet recruiting
Phase 3

Effectiveness of multi-modal interventions on Quality of life, symptom burdens and self-efficacy among ovarian cancer patients in a selected oncology hospital, Kolkata.

Chaitali Biswas1 site in 1 country200 target enrollmentStarted: August 1, 2024Last updated:

Overview

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Chaitali Biswas
Enrollment
200
Locations
1
Primary Endpoint
To evaluate the effect of multi-modal interventions on Quality of life, Symptom management and self-efficacy among ovarian cancer pateints

Overview

Brief Summary

This study is a single-center, randomized, parallel-group open trial to assess the effectiveness of multi-modal interventions on quality of life, symptom burdens, and self-efficacy among ovarian cancer patients in a selected oncology hospital, Kolkata. The study aims to prepare & implement multi-modal interventions to determine QOL, symptom burdens & self-efficacy among Ovarian cancer patients. The study will follow an RCT design for 9 months of each patient’s coverage. Multi-modal interventions include four multi-component nursing intervention sessions (Pre-treatment session, Sensitization session, Prehabilitation session, and Symptom management session) through various modes of instruction; each session will be on Four different days within the period of 1 to 21 days. It will be given only to the experimental group of ovarian cancer patients undergoing treatment with surgery or chemotherapy to improve their Quality of life and self-efficacy and to reduce their symptom burdens. Multi-modal interventions will be reinforced and monitored through telephonic conversation and in each follow-up visit at the Outpatient department every three months till six months of the treatment. 

Standardized tools will be used to collect data as a baseline & every 3-month intervals after the implementation of the intervention for both groups of participants. The study’s primary objective is to evaluate the effect of multi-modal interventions on quality of life, symptom burdens, and self-efficacy among ovarian cancer patients. The secondary outcome is encouraging and motivating the individual to adapt the intervention daily to improve self-efficacy, self-management, and health-related quality of life. Based on the findings, this can be implemented as routine care for ovarian cancer patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
19.00 Year(s) to 60.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Newly diagnosed Ovarian cancer patients
  • With any stage from II, III, and IV.
  • Eastern Cooperative Oncology group (ECOG) performance status within
  • Planned for initial treatment either with chemotherapy or Surgery.
  • Able to understand, read, and write Bengali or Hindi or English.

Exclusion Criteria

  • Ovarian cancer patients who are
  • Critically ill.
  • ECOG performance status more than
  • Diagnosed as a relapse of ovarian cancer patients.
  • under palliative care.

Outcomes

Primary Outcomes

To evaluate the effect of multi-modal interventions on Quality of life, Symptom management and self-efficacy among ovarian cancer pateints

Time Frame: Quality of life, Symptom burdens, and self-efficacy as the outcome of the multi-modal intervention will be assessed at baseline, 3 month, 6 month and 9 month for both experimental arm and control arm

Secondary Outcomes

  • To encourage and motivate the individual Ovarian cancer patients under study to adapt the intervention in their daily life and thus to improve the self-efficacy and self management of symptoms and health related quality of life(at 9 months after the study as well as continue throughout the survival period)

Investigators

Sponsor
Chaitali Biswas
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Chaitali Biswas

Tata Medical Center

Study Sites (1)

Loading locations...

Similar Trials